Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.500
-0.050 (-3.23%)
At close: May 12, 2026, 4:00 PM EDT
1.590
+0.090 (6.00%)
After-hours: May 12, 2026, 7:13 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $33.63 million as of May 12, 2026. Its market cap has increased by 2.58% in one year.
Market Cap
33.63M
Enterprise Value
-10.93M
1-Year Change
2.58%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $33.63M, a decrease of -90.55%. That is a compound annual growth rate of -67.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 34.75M | 29.36% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apollomics | 33.93M |
| NanoViricides | 33.47M |
| Werewolf Therapeutics | 33.05M |
| Palatin Technologies | 32.79M |
| Sensei Biotherapeutics | 31.36M |
| Tevogen Bio Holdings | 31.15M |
| NeuroSense Therapeutics | 31.11M |
| IGC Pharma | 30.73M |